BIOMAT Database Logo BIOMAT Database Logo

Insulin, insulin-like growth factor I (IGF-I), IGF-binding protein-1, growth hormone, and feeding in the newborn. 1998

A L Ogilvy-Stuart, and S J Hands, and C J Adcock, and J M Holly, and D R Matthews, and V Mohamed-Ali, and J S Yudkin, and A R Wilkinson, and D B Dunger
Department of Pediatrics, University of Oxford, United Kingdom. amanda.ogilvy-stuart@msexc.addenbrookes.anglox.nhs.uk

The relationship between GH, insulin-like growth factor I (IGF-I), IGF-binding protein-1 (IGFBP-1), and insulin may be critical to the understanding of variation in early growth, especially in the small for gestational age (SGA) baby. To investigate these relationships, we have undertaken 12-h hormone profiles in 26 babies (13 SGA) at a median of 4.5 days of age. GH levels were measured every 10 min; insulin and IGFBP-1 were measured every 20 min. Mean levels of these hormones and IGF-I levels (from a single sample) were related to size at birth. The GH data were analyzed by Pulsar and time series analysis to characterize hormone pulsatility and relationship with feeds. IGF-I levels correlated with birth weight and length (r2 = 0.47; P = 0.004, and r2 = 0.5; P = 0.0005, respectively, after allowing for gestation), whereas mean GH levels were negatively related to birth size (r2 = -0.18; P = 0.04 and r2 = -0.2; P = 0.03 for weight and length, respectively). No direct relationship between mean GH levels and IGF-I was identified. IGF-I levels were higher in appropriate for gestational age (AGA; mean +/- SD, 82+/-61 ng/mL) than in SGA (34+/-22 ng/mL; P = 0.03) babies. Baseline (mean +/- SD, 25.9+/-11.9), mean (33.9+/-14.0), and peak (45.0+/-18.1 microg/L) GH levels were higher in SGA than in AGA babies [17.1+/-8.2 (P = 0.04), 22.5+/-10.4 (P = 0.03), and 30.7+/-15.4 microg/L (P = 0.04), respectively]. Mean IGFBP-1 levels were also higher in SGA than AGA babies (157.4+/-90.7 vs. 62.7+/-43.8 ng/mL; P = 0.01). A positive correlation was identified between changes in insulin and coincident pulses of GH (r = 0.147; P < 0.01), whereas there was an inverse relationship between insulin and IGFBP-1, with a lag time 120 min (r = -0.33; P < 0.0001). In conclusion, these studies indicate that the GH-IGF-I axis is closely related to feeding in the newborn. In SGA babies, low IGF-I and elevated IGFBP-1 reflect the slow growth, but elevated GH and rapid GH pulsatility may be a signal for lipolysis.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007236 Infant, Small for Gestational Age An infant having a birth weight lower than expected for its gestational age.
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007334 Insulin-Like Growth Factor I A well-characterized basic peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like, and mitogenic activities. This growth factor has a major, but not absolute, dependence on GROWTH HORMONE. It is believed to be mainly active in adults in contrast to INSULIN-LIKE GROWTH FACTOR II, which is a major fetal growth factor. IGF-I,Somatomedin C,IGF-1,IGF-I-SmC,Insulin Like Growth Factor I,Insulin-Like Somatomedin Peptide I,Insulin Like Somatomedin Peptide I
D008297 Male Males
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D004435 Eating The consumption of edible substances. Dietary Intake,Feed Intake,Food Intake,Macronutrient Intake,Micronutrient Intake,Nutrient Intake,Nutritional Intake,Ingestion,Dietary Intakes,Feed Intakes,Intake, Dietary,Intake, Feed,Intake, Food,Intake, Macronutrient,Intake, Micronutrient,Intake, Nutrient,Intake, Nutritional,Macronutrient Intakes,Micronutrient Intakes,Nutrient Intakes,Nutritional Intakes
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D018970 Insulin-Like Growth Factor Binding Protein 1 One of the six homologous proteins that specifically bind insulin-like growth factors (SOMATOMEDINS) and modulate their mitogenic and metabolic actions. The function of this protein is not completely defined. However, several studies demonstrate that it inhibits IGF binding to cell surface receptors and thereby inhibits IGF-mediated mitogenic and cell metabolic actions. (Proc Soc Exp Biol Med 1993;204(1):4-29) IGF-Binding Protein 1,IGFBP-1,IGF Binding Protein 1,Insulin Like Growth Factor Binding Protein 1

Related Publications

A L Ogilvy-Stuart, and S J Hands, and C J Adcock, and J M Holly, and D R Matthews, and V Mohamed-Ali, and J S Yudkin, and A R Wilkinson, and D B Dunger
Inter-relations between growth hormone, insulin, insulin-like growth factor-I (IGF-I), IGF-binding protein-1 (IGFBP-1) and sex hormone-binding globulin in acromegaly.
April 1991, Clinical endocrinology,
A L Ogilvy-Stuart, and S J Hands, and C J Adcock, and J M Holly, and D R Matthews, and V Mohamed-Ali, and J S Yudkin, and A R Wilkinson, and D B Dunger
Growth hormone-stimulated insulin-like growth factor (IGF) I and IGF-binding protein-3 in liver cirrhosis.
November 1997, Journal of hepatology,
A L Ogilvy-Stuart, and S J Hands, and C J Adcock, and J M Holly, and D R Matthews, and V Mohamed-Ali, and J S Yudkin, and A R Wilkinson, and D B Dunger
Bioactive insulin-like growth factor (IGF) I and IGF-binding protein-1 in anorexia nervosa.
June 2007, The Journal of clinical endocrinology and metabolism,
A L Ogilvy-Stuart, and S J Hands, and C J Adcock, and J M Holly, and D R Matthews, and V Mohamed-Ali, and J S Yudkin, and A R Wilkinson, and D B Dunger
Insulin-like growth factor-I (IGF-I) and IGF-I binding protein in the follicular fluids of growth hormone treated patients.
April 1990, Clinical endocrinology,
A L Ogilvy-Stuart, and S J Hands, and C J Adcock, and J M Holly, and D R Matthews, and V Mohamed-Ali, and J S Yudkin, and A R Wilkinson, and D B Dunger
Effect of intraperitoneal insulin delivery on growth hormone binding protein, insulin-like growth factor (IGF)-I, and IGF-binding protein-3 in IDDM.
December 1996, Diabetologia,
A L Ogilvy-Stuart, and S J Hands, and C J Adcock, and J M Holly, and D R Matthews, and V Mohamed-Ali, and J S Yudkin, and A R Wilkinson, and D B Dunger
Changes in insulin-like growth factor-I (IGF-I), IGF-binding protein-3, growth hormone (GH)-binding protein, erythrocyte IGF-I receptors, and growth rate during GH treatment.
January 1995, The Journal of clinical endocrinology and metabolism,
A L Ogilvy-Stuart, and S J Hands, and C J Adcock, and J M Holly, and D R Matthews, and V Mohamed-Ali, and J S Yudkin, and A R Wilkinson, and D B Dunger
Serum levels of insulin-like growth factor I (IGF-I) and IGF binding protein 3 reflect spontaneous growth hormone secretion.
June 1993, The Journal of clinical endocrinology and metabolism,
A L Ogilvy-Stuart, and S J Hands, and C J Adcock, and J M Holly, and D R Matthews, and V Mohamed-Ali, and J S Yudkin, and A R Wilkinson, and D B Dunger
Recombinant human insulin-like growth factor (IGF)-binding protein-1 inhibits somatic growth stimulated by IGF-I and growth hormone in hypophysectomized rats.
November 1994, Endocrinology,
A L Ogilvy-Stuart, and S J Hands, and C J Adcock, and J M Holly, and D R Matthews, and V Mohamed-Ali, and J S Yudkin, and A R Wilkinson, and D B Dunger
Insulin-like growth factor-I (IGF-1), IGF-binding protein-3 (IGFBP-3) and mammographic features.
May 2012, Il Giornale di chirurgia,
A L Ogilvy-Stuart, and S J Hands, and C J Adcock, and J M Holly, and D R Matthews, and V Mohamed-Ali, and J S Yudkin, and A R Wilkinson, and D B Dunger
Effects of porcine growth hormone and insulin-like growth factor-I (IGF-I) on immunoreactive IGF-binding protein concentration in pigs.
January 1989, The Journal of endocrinology,
Copied contents to your clipboard!